Equities

Yestar Healthcare Holdings Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Yestar Healthcare Holdings Co Ltd

Actions
  • Price (HKD)0.118
  • Today's Change-0.005 / -4.07%
  • Shares traded322.50k
  • 1 Year change+78.79%
  • Beta1.1269
Data delayed at least 15 minutes, as of Feb 16 2026 02:13 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Yestar Healthcare Holdings Co Ltd is an investment holding principally engaged in the manufacture, distribution and sales of medical imaging products, distribution of in vitro diagnostic products, as well as the manufacture and sales of dental films. The Company operates its businesses through two business segments. The Imaging Printing Products segment engages in the manufacture and sales of color photographic paper, industrial non-destructive testing (NDT) x-ray films and printed wire board (PWB) films, as well as trading of imaging equipment. The Medical Products and Equipment segment engages in the manufacture and sales of medical dry films, medical wet films and dental films, as well as the sales of medical equipment and diagnostic reagents. The Company mainly conducts its businesses within domestic market.

  • Revenue in HKD (TTM)2.19bn
  • Net income in HKD-183.11m
  • Incorporated2012
  • Employees479.00
  • Location
    Yestar Healthcare Holdings Co LtdRoom 805, Block 2No. 58 Shen Jian Dong Lu, Min Hang Dist.Min Hang Dist.SHANGHAI ChinaCHN
  • Phone+86 2 164890111
  • Fax+86 2 164890555
  • Websitehttp://www.yestarcorp.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.